These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25715244)

  • 61. HAE update: determining optimal patient specific therapy.
    Gower RG
    Allergy Asthma Proc; 2013; 34(1):7-12. PubMed ID: 23406928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Managed care implications of hereditary angioedema.
    Cardarelli W
    Am J Manag Care; 2013 Jun; 19(7 Suppl):s119-24. PubMed ID: 23844784
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.
    Kreuz W; Rusicke E; Martinez-Saguer I; Aygören-Pürsün E; Heller C; Klingebiel T
    Transfusion; 2012 Jan; 52(1):100-7. PubMed ID: 21756262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
    Nzeako UC; Longhurst HJ
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current medical management of hereditary angioedema: follow-up survey of US physicians.
    Riedl MA; Banerji A; Gower R
    J Allergy Clin Immunol Pract; 2015; 3(2):220-7. PubMed ID: 25609328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hereditary angioedema: current and emerging treatment options.
    Levy JH; Freiberger DJ; Roback J
    Anesth Analg; 2010 May; 110(5):1271-80. PubMed ID: 20418292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
    Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful resolution of bowel obstruction in a patient with hereditary angioedema.
    Zingale LC; Zanichelli A; Deliliers DL; Rondonotti E; De Franchis R; Cicardi M
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):583-7. PubMed ID: 18467921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hereditary angioedema: management of laryngeal attacks.
    Christiansen SC; Zuraw BL
    Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.
    Caballero T; Maurer M; Longhurst HJ; Aberer W; Bouillet L; Fabien V;
    J Investig Allergol Clin Immunol; 2016; 26(6):383-386. PubMed ID: 27996949
    [No Abstract]   [Full Text] [Related]  

  • 75. Economic costs associated with acute attacks and long-term management of hereditary angioedema.
    Wilson DA; Bork K; Shea EP; Rentz AM; Blaustein MB; Pullman WE
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):314-20. PubMed ID: 20408341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current medical management of hereditary angioedema: results from a large survey of US physicians.
    Riedl M; Gower RG; Chrvala CA
    Ann Allergy Asthma Immunol; 2011 Apr; 106(4):316-322.e4. PubMed ID: 21457880
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
    Bernstein JA; Manning ME; Li H; White MV; Baker J; Lumry WR; Davis-Lorton MA; Jacobson KW; Gower RG; Broom C; Fitts D; Schranz J
    J Allergy Clin Immunol Pract; 2014; 2(1):77-84. PubMed ID: 24565773
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meeting the challenges and burdens associated with hereditary angioedema.
    Toscani M; Riedl M
    Manag Care; 2011 Sep; 20(9):44-51. PubMed ID: 21991862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.
    Petraroli A; Squeglia V; Di Paola N; Barbarino A; Bova M; Spanò R; Marone G; Triggiani M
    Int Arch Allergy Immunol; 2015; 166(4):259-66. PubMed ID: 25924832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.
    Lumry WR; Castaldo AJ; Vernon MK; Blaustein MB; Wilson DA; Horn PT
    Allergy Asthma Proc; 2010; 31(5):407-14. PubMed ID: 20929608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.